These findings identify HMGB1 as a novel regulator of SG dynamics under hypoxia and suggest that manipulation of HMGB1 lactylation may modulate both inflammatory and stress‐response pathways in hypoxia‐related pathologies, including cancer. The gene discussed is HMGB1; the disease is cancer.